Pituitary Apoplexy Induced by a Combined Anterior Pituitary Test: Case Report and Literature Review

Fumio Otsuka, Jingo Kageyama, Toshio Ogura, Hirofumi Makino

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

We report the case of a 31-year-old woman with a pituitary adenoma who suffered symptomatic pituitary apoplexy. The patient developed a severe headache 2 min after undergoing a combined anterior pituitary function (CAP) test. Emergent computed tomography revealed a hemorrhagic pituitary tumor with evidence of a small subarachnoid hemorrhage. The headache improved spontaneously within half a day. Transsphenoidal surgery was performed 4 days later. Histologic examination demonstrated that the tumor was an eosinophilic adenoma with areas of diffuse hemorrhage. Although pituitary apoplexy caused by endocrinological testing has been reported in only 28 patients, apoplexy caused by a CAP test has been reported in only 1 patient. All of the previous cases had pituitary macroadenomas, 69% of which were involved in suprasellar extension. Non-functioning adenomas (24%) and prolactinomas (24%) were the most often affected by endocrine stimulation tests. With respect to the stimulants of pituitary adenomas, gonadotropin-releasing hormone (76%), TSH-releasing hormone (69%), and insulin (34%) were primarily responsible for the apoplexy. This case report with the literature review suggests that routine testing on pituitary function should be ordered cautiously given the risk of possible apoplexy.

Original languageEnglish
Pages (from-to)393-398
Number of pages6
JournalEndocrine Journal
Volume45
Issue number3
Publication statusPublished - 1998

Fingerprint

Pituitary Apoplexy
Pituitary Function Tests
Pituitary Neoplasms
Stroke
Headache
Acidophil Adenoma
Pituitary Gonadotropins
Prolactinoma
Subarachnoid Hemorrhage
Gonadotropin-Releasing Hormone
Adenoma
Tomography
Hormones
Insulin
Hemorrhage
Neoplasms

Keywords

  • Acromegaly
  • Combined anterior pituitary (CAP) test
  • Endocrinologic stimulation tests
  • Pituitary adenoma
  • Pituitary apoplexy

ASJC Scopus subject areas

  • Endocrinology

Cite this

Pituitary Apoplexy Induced by a Combined Anterior Pituitary Test : Case Report and Literature Review. / Otsuka, Fumio; Kageyama, Jingo; Ogura, Toshio; Makino, Hirofumi.

In: Endocrine Journal, Vol. 45, No. 3, 1998, p. 393-398.

Research output: Contribution to journalArticle

@article{404fe5195a1345fba0dc22dd84b6de1e,
title = "Pituitary Apoplexy Induced by a Combined Anterior Pituitary Test: Case Report and Literature Review",
abstract = "We report the case of a 31-year-old woman with a pituitary adenoma who suffered symptomatic pituitary apoplexy. The patient developed a severe headache 2 min after undergoing a combined anterior pituitary function (CAP) test. Emergent computed tomography revealed a hemorrhagic pituitary tumor with evidence of a small subarachnoid hemorrhage. The headache improved spontaneously within half a day. Transsphenoidal surgery was performed 4 days later. Histologic examination demonstrated that the tumor was an eosinophilic adenoma with areas of diffuse hemorrhage. Although pituitary apoplexy caused by endocrinological testing has been reported in only 28 patients, apoplexy caused by a CAP test has been reported in only 1 patient. All of the previous cases had pituitary macroadenomas, 69{\%} of which were involved in suprasellar extension. Non-functioning adenomas (24{\%}) and prolactinomas (24{\%}) were the most often affected by endocrine stimulation tests. With respect to the stimulants of pituitary adenomas, gonadotropin-releasing hormone (76{\%}), TSH-releasing hormone (69{\%}), and insulin (34{\%}) were primarily responsible for the apoplexy. This case report with the literature review suggests that routine testing on pituitary function should be ordered cautiously given the risk of possible apoplexy.",
keywords = "Acromegaly, Combined anterior pituitary (CAP) test, Endocrinologic stimulation tests, Pituitary adenoma, Pituitary apoplexy",
author = "Fumio Otsuka and Jingo Kageyama and Toshio Ogura and Hirofumi Makino",
year = "1998",
language = "English",
volume = "45",
pages = "393--398",
journal = "Endocrine Journal",
issn = "0918-8959",
publisher = "Japan Endocrine Society",
number = "3",

}

TY - JOUR

T1 - Pituitary Apoplexy Induced by a Combined Anterior Pituitary Test

T2 - Case Report and Literature Review

AU - Otsuka, Fumio

AU - Kageyama, Jingo

AU - Ogura, Toshio

AU - Makino, Hirofumi

PY - 1998

Y1 - 1998

N2 - We report the case of a 31-year-old woman with a pituitary adenoma who suffered symptomatic pituitary apoplexy. The patient developed a severe headache 2 min after undergoing a combined anterior pituitary function (CAP) test. Emergent computed tomography revealed a hemorrhagic pituitary tumor with evidence of a small subarachnoid hemorrhage. The headache improved spontaneously within half a day. Transsphenoidal surgery was performed 4 days later. Histologic examination demonstrated that the tumor was an eosinophilic adenoma with areas of diffuse hemorrhage. Although pituitary apoplexy caused by endocrinological testing has been reported in only 28 patients, apoplexy caused by a CAP test has been reported in only 1 patient. All of the previous cases had pituitary macroadenomas, 69% of which were involved in suprasellar extension. Non-functioning adenomas (24%) and prolactinomas (24%) were the most often affected by endocrine stimulation tests. With respect to the stimulants of pituitary adenomas, gonadotropin-releasing hormone (76%), TSH-releasing hormone (69%), and insulin (34%) were primarily responsible for the apoplexy. This case report with the literature review suggests that routine testing on pituitary function should be ordered cautiously given the risk of possible apoplexy.

AB - We report the case of a 31-year-old woman with a pituitary adenoma who suffered symptomatic pituitary apoplexy. The patient developed a severe headache 2 min after undergoing a combined anterior pituitary function (CAP) test. Emergent computed tomography revealed a hemorrhagic pituitary tumor with evidence of a small subarachnoid hemorrhage. The headache improved spontaneously within half a day. Transsphenoidal surgery was performed 4 days later. Histologic examination demonstrated that the tumor was an eosinophilic adenoma with areas of diffuse hemorrhage. Although pituitary apoplexy caused by endocrinological testing has been reported in only 28 patients, apoplexy caused by a CAP test has been reported in only 1 patient. All of the previous cases had pituitary macroadenomas, 69% of which were involved in suprasellar extension. Non-functioning adenomas (24%) and prolactinomas (24%) were the most often affected by endocrine stimulation tests. With respect to the stimulants of pituitary adenomas, gonadotropin-releasing hormone (76%), TSH-releasing hormone (69%), and insulin (34%) were primarily responsible for the apoplexy. This case report with the literature review suggests that routine testing on pituitary function should be ordered cautiously given the risk of possible apoplexy.

KW - Acromegaly

KW - Combined anterior pituitary (CAP) test

KW - Endocrinologic stimulation tests

KW - Pituitary adenoma

KW - Pituitary apoplexy

UR - http://www.scopus.com/inward/record.url?scp=0032082344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032082344&partnerID=8YFLogxK

M3 - Article

C2 - 9790275

AN - SCOPUS:0032082344

VL - 45

SP - 393

EP - 398

JO - Endocrine Journal

JF - Endocrine Journal

SN - 0918-8959

IS - 3

ER -